NCT05248763Recruiting
Taiwan Cancer Moonshot Project
Taiwan Cancer Moonshot Project: 1. Next-generation Pathway of Taiwan Cancer Precision Medicine (Subjective Aim 1- Taiwan Cancer Moonshot Project); 2. Development of Novel Treatments for Major Diseases (Subproject 5 - Multiomic Big Data-based Intelligent Navigation System for Precision Oncology)
Source: ClinicalTrials.gov · Last updated 20 Jul 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to establish multiomic big data under strictly collected clinical samples from tumors, adjacent normal tissue, blood, and clinical data then analyze by using integrated proteomics and genetics platform.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4190 (estimated)
- First submitted
- 24 Jan 2022
- Start date
- 21 Feb 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Academia Sinica, Taiwan
- NCT number
- NCT05248763
What you commit to
- Study type: Observational
- Planned participants: 4190
- From 21 Feb 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- other cancer types
Who the study is looking for
- lung cancer, breast cancer, gastric cancer, pancreatic cancer, ovarian cancer
Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.